10.1002/adsc.201900009
Advanced Synthesis & Catalysis
(s, 2H, A), 4.02 (s, 2H, B), 3.50 – 3.39 (m, 2H, A + B), 3.37
(t, J = 6.7 Hz, 2H, A), 3.30 (t, J = 6.6 Hz, 2H, B), 1.93 –
1.74 (m, 2H, A + B); 13C NMR (100 MHz, CDCl3):
(mixture of rotamers) = 169.3 and 169.2, 156.1 and 155.6,
136.1, 135.1 and 135.0, 128.3, 128.3, 128.2, 128.2, 128.1,
128.0, 127.9, 127.8, 127.7, 127.5, 67.4 and 67.2, 66.72and
66.69, 49.5 and 49.4, 48.6 and 48.4, 46.4, 45.6, 27.6 and
27.3; HPLC-MS (ESI): 355 [M + H+− N2], 383 [M + H+],
405 [M + Na+]. C20H22N4O4 (382.42): calcd C 62.82, H 5.80;
N 14.65; found C 63.02, H 5.76, N 14.50.
Supported catalyst 3. Step vi (Scheme 3). Pristine C60
(0.168 g, 0.23 mmol) was dissolved in toluene (60 mL) and
was sonicated for 20 min under inert atmosphere. 12 (0.117
g, 0.19 mmol) and paraformaldehyde (0.014 g, 0.47 mmol)
were added to the solution and the reaction mixture was
refluxed for 1 h. The solution was cooled to RT and directly
purified by flash-chromatography on SiO2 (first only
toluene to remove unreacted C60, then toluene/AcOEt 7:3)
affording the N-Boc protected supported catalyst (0.131 g,
0.099 mmol, 53 %) as a brown powder. 1H NMR (400 MHz,
CDCl3) δ = 7.80 (s, 1H), 7.47 – 7.38 (m, 6H), 7.24 – 7.18
(m, 6H), 7.17 – 7.10 (m, 3H), 5.86 (s, 1H), 4.82 (t, J = 6.9
Hz, 2H), 4.70 (d, J = 12.3 Hz, 1H), 4.51 (d, J = 12.4 Hz, 1H),
4.47 – 4.43 (m, 4H), 4.12 (d, J = 5.2 Hz, 1H), 3.48 (q, J =
9.5 Hz, 1H), 3.16 (broad t, J = 6.6 Hz, 2H), 2.92 (td, J = 10.7,
2.6 Hz, 1H), 2.58 (broad dt, J = 13.0, 5.6 Hz, 2H), 1.63 –
1.52 (m, 1H), 1.32 (s, 9H), -0.10 (ddt, J = 19.4, 9.5, 5.2 Hz,
1H); 13C NMR (100 MHz, CDCl3) δ= 157.2, 147.3, 146.3,
146.1, 145.9, 145.7, 145.5, 145.3, 144.7, 144.6, 143.1, 142.7,
142.2, 142.1, 141.9, 140.2, 136.2, 130.7, 129.0, 128.6, 127.3,
126.0, 123.1, 83.3, 71.1, 70.5, 67.6, 61.6, 61.0, 51.1, 49.4,
48.3, 29.7, 28.3, 26.8. Step vii (Scheme 3). The N-Boc
protected catalyst (0.140 g, 0.106 mmol) was dissolved in
CH2Cl2 (20 mL) and was sonicated for 20 min. TFA (1 mL,
13.3 mmol) was added dropwise at 0 °C to the solution and
the reaction mixture was stirred at RT overnight. The
organic solvent was removed under vacuum and the crude
solid was re-dissolved in CH2Cl2/H2O (10 mL + 10 mL).
The organic phase was collected and the aqueous phase was
extracted with CH2Cl (3 × 10 mL). The combined organic
phases were dried (Na2SO4), filtered and evaporated under
reduced pressure. Purification by flash-chromatography on
silica (CH2Cl2/MeOH 99:1) afforded 3 (0.128 g, 0.105
(3-(4-((((2S,3R)-N-Boc-2-tritylpyrrolidin-3-
yl)oxy)methyl)-1H-1,2,3-triazol-1-yl) propyl) glycine
(12). Step iv (Scheme 3). A solution of CuSO4·5H2O (0.011
g, 0.043 mmol) in H2O (0.5 mL) and a solution of sodium
ascorbate (0.017 g, 0.086 mmol) in H2O (0.5 mL) were
slowly added to a stirred solution of 11 (0.164 g, 0.43 mmol)
and 9 (0.201 g, 0.43 mmol) in t-butanol (1 mL) and the
resulting suspension was stirred at RT overnight. The
reaction mixture was diluted with AcOEt (5 mL), the
organic phase was collected and the aqueous phase was
extracted with AcOEt (3 × 5 mL). The combined organic
phases were dried (Na2SO4), filtered and evaporated under
reduced pressure. Purification by flash-chromatography on
silica (cyclohexane/AcOEt 8:2) afforded 0.34 g of the
corresponding triazole (0.4 mmol, 93 %). [α]D25 = −50.4 (c
= 0.78, CHCl3); 1H NMR (400 MHz, CDCl3) δ =7.71 (s, 1H),
7.47 – 7.36 (m, 6H), 7.37 – 7.30 (m, 6H), 7.30 – 7.27 (m,
2H), 7.19 (t, J = 7.2 Hz, 6H), 7.16 – 7.10 (m, 3H), 5.83 (s,
1H), 5.19 (s, 1H), 5.12 (d, J = 2.7 Hz, 2H), 4.61 (dd, J =
26.0, 12.3 Hz, 1H), 4.49 – 4.30 (m, 3H), 4.14 – 4.01 (m, 3H),
3.58 – 3.38 (m, 3H), 2.91 (td, J = 10.6, 2.7 Hz, 1H), 2.16
(dq, J = 11.7, 6.1 Hz, 2H), 1.63 – 1.49 (m, 1H), 1.32 (s, 9H),
-0.12 (dtd, J = 14.8, 9.6, 5.2 Hz, 1H); 13C NMR (100 MHz,
CDCl3) δ (mixture of rotamers) =169.7, 157.1, 156.2, 144.9,
144.7, 136.1, 135.2, 135.1, 130.7, 128.7, 128.6, 128.5, 128.5,
128.4, 128.3, 128.3, 128.1, 127.8, 127.3, 125.9, 125.9, 123.3,
122.5, 83.2, 83.1, 79.7, 71.1, 67.9, 67.7, 67.1, 61.4, 61.0,
50.0, 49.7, 49.4, 47.6, 46.4, 45.9, 29.7, 29.4, 29.2, 28.2,
26.7; HPLC-MS (ESI): 850 [M + H+]. C51H55N5O7 (850.03):
calcd C 72.06, H 6.52, N 8.24; found C 72.19 H 6.47, N 8.16.
Step v (Scheme 3): Pd/C (10 % w/w, 0.03 g, 0.028 mmol)
was added to a solution of the protected triazole (0.239 g,
0.28 mmol) in MeOH (3 mL) and the reaction mixture was
kept stirring under H2 (1 atm) overnight. The catalyst was
removed by filtration on Celite®, the filter cake was washed
with MeOH and the solvent was removed under reduced
pressure to afford pure 12 (0.175 g, 0.28 mmol, 99 %) as a
1
mmol, 99 %) as a brown powder. H NMR (400 MHz,
CDCl3) δ = 7.78 (s, 1H), 7.46 – 7.31 (m, 6H), 7.28 – 7.19
(m, 6H), 7.20 –.11 (m, 3H), 4.91 (s, 1H), 4.81 (t, J = 6.8 Hz,
2H), 4.67 (d, J = 12.0 Hz, 1H), 4.46 (d, J = 12.2 Hz, 1H),
4.44 – 4.39 (m, 4H), 3.90 (d, J = 4.8 Hz, 1H), 3.13 (t, J =
6.6 Hz, 2H), 2.97 (td, J = 10.4, 5.3 Hz, 1H), 2.77 (t, J = 8.4
Hz, 1H), 2.55 (p, J = 6.8 Hz, 2H), 1.67 (dd, J = 13.4, 5.5 Hz,
1H), 0.55 – 0.32 (m, 1H); 13C NMR (100 MHz, CDCl3) δ =
154.7, 147.3, 146.3, 146.1, 145.9, 145.6, 145.5, 145.4, 145.3,
144.6, 136.1, 130.0, 127.6, 126.0, 123.1, 83.3, 70.9, 70.6,
67.7, 62.7, 61.0, 50.7, 48.1, 44.9, 30.5, 29.1; MS (ESI): 1214
(100 %), 1215 (98 %), 1216 (35 %), 1217 (14 %) [M + H+].
C91H35N5O (1213.28); isotopic pattern prediction: 1213.28
(100 %), 1214.28 (98 %), 1215.96 (43 %), 1216.29 (12 %).
25
Michael addition of malonates to unsaturated aldehydes
(Table 2, Entry 16). Catalyst 3 (0.121 g, 0.05 mmol, 5
mol %) was dissolved in CH2Cl2 (4 mL) and sonicated for 5
min. (E)-cynnamaldehyde 15a (0.252 mL, 2 mmol), dry
LiOAc (0.0198 g, 0.15 mmol, 15 mol%) and
dimethylmalonate 14a (0.686 mL, 6 mmol) were added to
the solution and the reaction was stirred at RT for the 16 h.
The reaction mixture was directly charged on the top of a
silica-gel column and the product 16a (0.478 g, 1.81 mmol,
90%) was isolated eluting with cyclohexane/AcOEt 8:2.
The product 16a was converted into the unsaturated Horner-
Wadsworth-Emmons ester derivative using commercial
ethyl (triphenylphosphoranylidene) acetate in CH2Cl2. The
corresponding derivative was purified by flash-
white solid. m. p. = 127-130 °C; [α]D = − 62.8 (c = 1.0,
CHCl3); 1H NMR (400 MHz, CDCl3) δ =7.72 (s, 1H), 7.38
(d, J = 7.8 Hz, 6H), 7.21 – 7.06 (m, 10H), 5.80 (s, 1H), 4.67
– 4.46 (m, 4H), 4.36 (d, J = 12.2 Hz, 1H), 4.06 (d, J = 5.2
Hz, 1H), 3.54 (s, 2H), 3.49 – 3.34 (m, 1H), 3.13 (broad t, J
= 7.7 Hz, 2H), 2.88 (dt, J = 10.7, 5.6 Hz, 1H), 2.45 (dt, J =
13.9, 6.5 Hz, 2H), 1.63 – 1.45 (m, 1H), 1.28 (s, 9H), 0.04 –
-0.37 (m, 1H); 13C NMR (100 MHz, CDCl3) δ(mixture of
rotamers) = 171.0, 156.9, 144.9, 144.5, 130.5, 127.2, 125.9,
125.8, 123.5, 83.3, 79.5, 70.9, 61.3, 60.9, 53.3, 50.2, 49.3,
47.3, 44.5, 28.1, 26.8; HPLC-MS (ESI): 626 [M + H+], 1251
[2M + H+]. C36H43N5O5 (625.77): calcd C 69.10, H 6.93, N
11.19; found C 69.06, H 6.88, N 11.27.
8
This article is protected by copyright. All rights reserved.